|
ÇÁ·Î±×·¥
|
¡Ø ¼¼ºÎÀÏÁ¤Àº »çÁ¤»ó º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.
|
1ÀÏÂ÷ (7¿ù 13ÀÏ, ¿ù) Prologue (Àå¼Ò: ºÎ»ê¹éº´¿ø ±¹Á¦È»óȸÀǽÇ) |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
12:30 ~ 13:10 |
Welcome Ceremony ȯ¿µ»ç Ä·ÇÁ Program Overview (Ä·ÇÁ staff ¼Ò°³ / Âü°¡ÀÚ ¼Ò°³) |
½ÅÀç±¹ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) ±èÁ¾·ü ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
13:10 ~ 14:00 |
Era of 4 P Medicine (Personalized, Predictive, Preventive and Participatory) |
½ÅÀç±¹ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
14:10 ~ 15:00 |
½Å¾à°³¹ß°úÁ¤¿¡¼ ÀÇ·áÀü¹®°¡ÀÇ ¿ªÇÒ, ºñÀü, öÇÐ |
¾ÈÁ¾È£ (Á¦¾àÀÇÇÐȸ ȸÀå) |
15:10 ~ 16:00 |
¼±¹è°¡ ¹Ù¶óº¸´Â ÀÇ°úÇÐÀÚÀÇ ±æ |
ÇѽÂÈÆ ±³¼ö (°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ) |
16:10 ~ 19:00 |
¸ÂÃãÄ¡·á ½Ã´ë¿¡ ³ªÀÇ ¾à¹°À¯ÀüÇü ¾Ë¾Æº¸±â À¯ÀüÇü ºÐ¼® ½Ç½À I (Genomic DNA ºÐ¸® ¹× PCR) |
±èÀº¿µ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) Â÷Àº¿µ ¿¬±¸¿ø (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
19:00 ~ |
Group Discussion I : Project ¼³¸í ¹× Presentation Plan Â¥±â |
Mentors |
2ÀÏÂ÷ (7¿ù 14ÀÏ, È) New drug development process (Àå¼Ò: ÀÇ°ú´ëÇÐ (¹ÌÁ¤)) |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 09:50 |
½Å¾à°³¹ß ¹°Áú µµÃâ °úÁ¤ ¹× ½Å¾àÈĺ¸¹°ÁúÀÇ ¾à¹°µ¿Å ¿¬±¸ (In Vitro ADME & Toxicology study) |
±èµ¿Çö ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
10:00 ~ 10:50 |
½Å¾à°³¹ß ÀÓ»ó½ÃÇè °³¿ä ¹× °úÁ¤ |
Á¤Áø¾Æ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
11:00 ~ 11:50 |
½Å¾à°³¹ß°úÁ¤ ±ÔÁ¦ °ü·Ã (¹ÌÁ¤) |
±èÈ£Á¤ ¿¬±¸°ü (½ÄÇ°ÀǾàÇ°¾ÈÀüó) |
12:00 ~ 13:50 |
CTC Åõ¾î ¹× Áᫎ |
Á¤Áø¾Æ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) À̵¿È¯ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
14:00 ~ 16:00 |
PGRC/BMRC Tour À¯ÀüÇü ºÐ¼® ½Ç½À II (SNaPshot analysis I) |
(¾à¹°À¯ÀüÇüºÐ¼®ÆÀ) |
16:00 ~ 16:20 |
Break |
|
16:20 ~ |
Group Discussion II: Team Meet with Mentors to Brainstorm Ideas for The Team's Plan
|
Mentors |
3ÀÏÂ÷ (7¿ù 15ÀÏ, ¼ö) Pharmacogenomics-based personalized medicine (Àå¼Ò: ÀÇ°ú´ëÇÐ(¹ÌÁ¤)) |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 09:10 |
ÇÐÀå´Ô Àλ縻¾¸ |
|
09:10 ~ 10:00 |
¾à¹°À¯Àüü ¿¬±¸ °³¿ä ¹× Áø´Ü±â¼ú |
½ÅÈ£Á¤ ¹Ú»ç (ÀÎÁ¦ÀÇ´ë ¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ) |
10:10 ~ 11:00 |
Therapeutic Drug Monitoring |
±èÀº¿µ ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
11:10 ~ 12:00 |
¹Ì·¡ÀÇÇÐÀÇ ÇöÁÖ¼Ò: ¾à¹°À¯Àüü ¸ÂÃãÄ¡·áÀÇ ÀÓ»óÀû¿ë»ç·Ê |
±èÈ£¼÷ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
12:10 ~ 18:00 |
À¯ÀüÇü ºÐ¼® ½Ç½À III (SNaPshot analysis II) / Áᫎ |
½Ç½ÀÁ¶±³ (¾à¹°À¯ÀüÇüºÐ¼®ÆÀ) |
18:00 ~ |
Group Discussion III: Discussion and Development of a Project Proposal |
Mentors |
4ÀÏÂ÷ (7¿ù 16ÀÏ, ¸ñ) Scope of Clinical pharmacology (Àå¼Ò: ÀÇ°ú´ëÇÐ(¹ÌÁ¤)) |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 09:50 |
ÀÓ»ó¾à¸®ÇÐÀÚÀÇ ¿ªÇÒ |
½ÅÀç±¹ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
10:00 ~ 10:50 |
Pharmacovigilance Practice |
¹ÚÂù¼± ±³¼ö (ÇØ¿î´ë¹éº´¿ø) |
11:00 ~ 11:50 |
ÀÓ»ó¾àÁ¦¼ºñ½º |
ÀÓ¿µÇØ °úÀå (ºÎ»ê¹éº´¿ø ¾àÁ¦ºÎ) |
12:00 ~ 13:00 |
Áᫎ |
|
13:00 ~ 13:50 |
In Silico: Beyond Medical Textbooks |
±èÁ¾·ü ±³¼ö (ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú) |
14:00 ~ 14:50 |
À¯ÀüÇü ºÐ¼® ½Ç½À IV (À¯ÀüÇü È®ÀÎ) |
±èÈ£¼÷ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
15:00 ~ 18:00 |
Group Discussion Final : Presentation Áغñ |
|
5ÀÏÂ÷ (7¿ù 17ÀÏ, ±Ý) Epilogue (Àå¼Ò: ºÎ»ê¹éº´¿ø ±¹Á¦È»óȸÀǽÇ) |
½Ã°£ |
ÁÖÁ¦ ¹× ³»¿ë |
¿¬ÀÚ |
09:00 ~ 12:30 |
Group Discussion Final: Presentation Áغñ |
|
12:30 ~ 13:00 |
Áغñ ¹× ¼³¹®ÁöÀÛ¼º |
|
13:00 ~ 15:30 |
Group Presentation / °¢ ÆÀº° 30ºÐ ¹ßÇ¥ (20ºÐ ¹ßÇ¥ / 10ºÐ ÁúÀÇ ÀÀ´ä) |
»çȸ: À̵¿È¯ ±³¼ö ½É»çÀ§¿ø: ½ÅÀç±¹, ±èµ¿Çö, ±èÀº¿µ, ¿À¹Î°æ |
15:30 ~ 16:00 |
Æóȸ»ç |
½ÅÀç±¹ ±³¼ö (ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç) |
18:30 ~ 21:00 |
¼Ûº° ¸¸Âù: Æóȸ½Ä ¹× ½Ã»ó½Ä ¼ö·áÁõ Àü´Þ, ½Ã»ó½Ä ÁøÇà |
»çȸ: ±èÁ¾·ü ±³¼ö |
|
|